Federal contractor profile

AZURE MEDICAL, INC.

UEI NBFFQRFZP5B8CAGE 9NED1Company website ↗

E
Small Business

Overview

Legal name
AZURE MEDICAL, INC.
Registered location
LA VERNE, CA, USA
Website
Company website ↗
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
Latest award activity
Nov 7, 2024
Read company summary

AZURE MEDICAL, INC. is associated with UEI NBFFQRFZP5B8 and CAGE 9NED1 in public federal records. AcornBids currently links 1 prime award totaling $61.2M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists LA VERNE, CA, USA.

At a glance

Lifetime prime obligations$61.2M
Prime awards1
Awards with future end dates0
Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 15, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
AZURE MEDICAL, INC.
UEI
NBFFQRFZP5B8
CAGE
9NED1
Registered address
1773 WRIGHT AVE, LA VERNE, CA, 91750, USA
Registration status
E
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
SAM activation
Mar 20, 2025
Initial registration
Aug 9, 2023
Entity start
Aug 4, 2023
SAM updated
Mar 19, 2026
Registration expires
Mar 19, 2026
Fiscal year end
Dec 31
Place of incorporation
TX, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 1 awards and $61,236,000 in reported obligations to this legal entity. Source
  • Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
  • An example award describes: OVER THE COUNTER (OTC) COVID-19 TESTS Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$0
Prime contracts

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 1 of 1 selected awards. Select a period to explore its awards.

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligationsNot reported
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$0
ChangeNot reported
GrowthNot comparable

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
CategoryPeriod obligationsAwards
Department of Health and Human Services$01
Offices
CategoryPeriod obligationsAwards
ASPR/DAAPPO/ORM HQ$01
Naics
Psc
Vehicles
CategoryPeriod obligationsAwards
Unclassified$01
States
CategoryPeriod obligationsAwards
OH$01
Set Asides
CategoryPeriod obligationsAwards
NO SET ASIDE USED.$01

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75A50223C00037OVER THE COUNTER (OTC) COVID-19 TESTSDepartment of Health and Human Services$61.2MSep 20, 2023Mar 19, 2025

Registration, certifications & contacts

Registration evidenceDate
SAM updatedMar 19, 2026
Source loadedSep 2, 2026
Initial registrationAug 9, 2023
Entity startAug 4, 2023

Registration classifications: Self Certified Small Disadvantaged Business, Small Business. These are separate from the reported certificates above.

IndustryReported size status
325412 — Pharmaceutical Preparation ManufacturingNot reported
325413 — In-Vitro Diagnostic Substance ManufacturingNot reported
339112 — Surgical and Medical Instrument ManufacturingNot reported
339113 — Surgical Appliance and Supplies ManufacturingNot reported
541713 — Research and Development in NanotechnologyNot reported
541714 — Research and Development in Biotechnology (except Nanobiotechnology)Not reported
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)Not reported
621511 — Medical LaboratoriesNot reported
ContactRolePublished contact methodsEvidenceSource date
FRANK LUOGovernment businessContact method not publishedSAM registrationNot available
FRANK LUOAlternate government businessContact method not publishedSAM registrationNot available
FRANK LUOElectronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 325412 — Pharmaceutical Preparation Manufacturing
  • 325413 — In-Vitro Diagnostic Substance Manufacturing
  • 339112 — Surgical and Medical Instrument Manufacturing
  • 339113 — Surgical Appliance and Supplies Manufacturing
  • 541713 — Research and Development in Nanotechnology
  • 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
  • 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  • 621511 — Medical Laboratories
Registered products and services
  • 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

GLOBAL BIOCLINICAL

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

SARTORIUS STEDIM NORTH AMERICA INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

10X GENOMICS, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
46 awards

CHONDREX, INC

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

MCKESSON MEDICAL-SURGICAL INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

BECTON, DICKINSON AND COMPANY

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit